233 results
Page 2 of 12
8-K
EX-99.1
i9ftz pd6
15 Jun 23
Regulation FD Disclosure
9:41am
8-K
EX-99.2
kgft9foilri
18 May 23
Regulation FD Disclosure
9:23pm
8-K
EX-99.1
1w316tb3nbj cw
18 May 23
Regulation FD Disclosure
9:23pm
8-K
EX-99.1
8w20lw
15 May 23
Regulation FD Disclosure
12:03pm
POS AM
pe3 zexj752i9j3io
12 May 23
Prospectus update (post-effective amendment)
5:28pm
8-K
EX-99.1
kk1xf2 da
2 May 23
Regulation FD Disclosure
7:33pm
8-K
EX-99.2
dedl j5vlr4htsk49g
2 May 23
Regulation FD Disclosure
7:33pm
8-K
EX-99.1
79t95lje6gk2 64
25 Apr 23
Regulation FD Disclosure
7:21pm
8-K
EX-10.1
bdqd6 w531c
30 Mar 23
Sorrento Therapeutics, Inc. Receives Final Court Approval for $75 Million Debtor-In-Possession Financing
9:39pm
8-K
EX-99.1
7b5p d5bbxh
30 Mar 23
Sorrento Therapeutics, Inc. Receives Final Court Approval for $75 Million Debtor-In-Possession Financing
9:39pm
8-K
EX-99.1
bho0k
29 Sep 22
Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Pay Off of Remaining Balance of its Senior Secured Notes
9:00am
425
EX-10.2
k7vivhp
13 Sep 22
Business combination disclosure
6:15pm
8-K
EX-10.2
tqhcsng
13 Sep 22
Entry into a Material Definitive Agreement
6:14pm
425
0uvfynv yr0x5skyi5
14 Jun 22
Business combination disclosure
2:51pm
8-K
EX-99.1
15k tjhro481
14 Jun 22
Entry into a Material Definitive Agreement
2:32pm
8-K
EX-99.1
wjfm 3bgf80g9c
3 Jun 22
Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Repurchase of $41.4 Million of its Senior Secured Notes
9:00am
8-K
EX-99.1
fw3pp6nayo svz
18 May 22
Sorrento Therapeutics, Inc. Appoints Former Roche Executive Tammy Reilly to the Board of Directors
4:02pm